Company Filing History:
Years Active: 2014
Title: Somnath Ambadas Khabale: Innovator in Pharmaceutical Processes
Introduction
Somnath Ambadas Khabale is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of complex compounds. His innovative approach has led to the development of a unique process that enhances the efficiency of drug synthesis.
Latest Patents
Somnath Khabale holds a patent for a process titled "Process for the preparation of tapentadol." This patent describes an improved method for synthesizing 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol and its pharmaceutically acceptable salt. The process involves the reaction of (S)-1-(dimethylamino)-2-methylpentan-3-one with 3-bromo anisole under Grignard conditions, leading to the formation of a key intermediate. This innovative method not only streamlines the synthesis but also enhances the overall yield of the desired compound.
Career Highlights
Somnath Khabale is associated with Indoco Remedies Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing their research and development efforts. With a focus on innovative drug formulations, Khabale continues to contribute to the field through his expertise and dedication.
Collaborations
Throughout his career, Somnath Khabale has collaborated with talented professionals, including Mangesh Narayan Rajadhyaksha and Ranjeet Nair. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical sciences.
Conclusion
Somnath Ambadas Khabale is a distinguished inventor whose work in pharmaceutical processes has made a significant impact. His innovative patent for the preparation of tapentadol showcases his expertise and commitment to advancing drug synthesis. Through his career at Indoco Remedies Limited and collaborations with fellow professionals, Khabale continues to push the boundaries of pharmaceutical innovation.